BioSig Technologies, Inc. (BSGM)
Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Frederick D. Hrkac | President, Principal Executive Officer & Executive VP | -- | -- | 1967 |
Dr. Budimir S. Drakulic Ph.D. | Chief Scientist | 169.64k | -- | 1950 |
Mr. Andrew Gornell Ballou | Vice President of Investor Relations | -- | -- | -- |
BioSig Technologies, Inc.
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 4
Description
BioSig Technologies, Inc., together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
Corporate Governance
Recent Events
- Apr 16, 202410-K: Periodic Financial ReportsSee Full Filing
- Apr 02, 2024NT 10-K: Periodic Financial ReportsSee Full Filing
- Mar 18, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Mar 12, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Mar 11, 20248-K: Corporate Changes & Voting MattersSee Full Filing
Upcoming Events
Upcoming Events Information Not Available